➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Dow
Johnson and Johnson
Moodys
Colorcon
AstraZeneca

Last Updated: December 5, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PENTOSAN POLYSULFATE SODIUM

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Pentosan Polysulfate Sodium

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003825 Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy Completed National Cancer Institute (NCI) Phase 3 1999-06-01 RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by previous radiation therapy to the abdomen and pelvis.
NCT00003825 Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy Completed Radiation Therapy Oncology Group Phase 3 1999-06-01 RATIONALE: Pentosan polysulfate may be effective in treating side effects of radiation therapy to the abdomen or pelvis. It is not yet known whether pentosan polysulfate is more effective than no further therapy for treating gastrointestinal disturbance caused by previous radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of pentosan polysulfate in treating patients who have inflammation of the rectum, diarrhea, or blood in stools caused by previous radiation therapy to the abdomen and pelvis.
NCT00086684 Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis Terminated Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 4 2003-09-01 The purpose of this study is to evaluate the safety and effectiveness of pentosan polysulfate sodium 100 mg once a day, pentosan polysulfate sodium 100 mg three times a day, and placebo for 24 weeks for the relief of bladder pain or discomfort associated with interstitial cystitis.
NCT00236990 An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland Completed Alza Corporation, DE, USA Phase 2 1969-12-31 The purpose of this study is to evaluate the safety and effectiveness of ELMIRON® in the treatment of chronic non-bacterial inflammation of the prostate gland.
NCT00236990 An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland Completed McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Phase 2 1969-12-31 The purpose of this study is to evaluate the safety and effectiveness of ELMIRON® in the treatment of chronic non-bacterial inflammation of the prostate gland.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pentosan Polysulfate Sodium

Condition Name

Condition Name for Pentosan Polysulfate Sodium
Intervention Trials
Interstitial Cystitis 2
Atrial Fibrillation 1
Radiation Enteritis 1
Psychotic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pentosan Polysulfate Sodium
Intervention Trials
Cystitis, Interstitial 2
Cystitis 2
Prostatitis 1
Schizophrenia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pentosan Polysulfate Sodium

Trials by Country

Trials by Country for Pentosan Polysulfate Sodium
Location Trials
United States 73
Canada 13
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pentosan Polysulfate Sodium
Location Trials
Texas 3
New York 3
Colorado 2
Nevada 2
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pentosan Polysulfate Sodium

Clinical Trial Phase

Clinical Trial Phase for Pentosan Polysulfate Sodium
Clinical Trial Phase Trials
Phase 4 2
Phase 3 1
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pentosan Polysulfate Sodium
Clinical Trial Phase Trials
Completed 3
Enrolling by invitation 1
Terminated 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pentosan Polysulfate Sodium

Sponsor Name

Sponsor Name for Pentosan Polysulfate Sodium
Sponsor Trials
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 1
Alza Corporation, DE, USA 1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pentosan Polysulfate Sodium
Sponsor Trials
Other 5
Industry 3
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Dow
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.